[使用卡伯戈林抑制哺乳后的精神病]
Amalie Munk Eefsen1, Linda Nielsen1, Sigrid Højmark Gimbel2
1Afdeling for Depression og Angst, Aarhus Universitetshospital, Psykiatrien.
Ugeskrift for laeger
|January 29, 2026
概括
卡伯戈林用于抑制哺乳期,可能会在患有产后抑郁症的妇女中引起罕见的精神病症状. 用抗精神病药物及电疗法 (ECT) 及时治疗导致症状改善.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 产后抑郁症 (PPD) 影响了许多女性.
- 哺乳抑制通常是用像卡伯戈林这样的药物来管理的.
- 在严重的PPD中,精神病症状可能会发生.
研究的目的:
- 在患有PPD的患者中报告卡贝戈林可能诱导的精神病症状病例.
- 为了突出卡贝戈林的罕见不良影响.
主要方法:
- 一个患有PPD的女性接受了卡贝戈林和塞特拉林治疗的病例报告.
- 在药物治疗开始后,对精神病症状的监测.
- 用抗精神病药物和电疗法 (ECT) 治疗.
主要成果:
- 患者最初通过卡伯戈林和塞特拉林得到改善.
- 在6天内,她出现了严重的精神病症状.
- 随着抗精神病药物和ECT的使用,症状迅速消失.
结论:
- 卡伯戈林可能与罕见的精神病性副作用有关.
- 卡贝戈林的长半衰期可能会导致症状延长.
- 早期识别和干预对于管理这种不良事件至关重要.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
8.1K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.5K
相关概念视频
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Psychosis: Goals of Pharmacotherapy
533
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
533
Psychosis and Antipsychotic Drugs: Overview
898
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
898
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.9K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.9K
Enzyme Inhibition
92.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.3K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
